CDRE — Cadre Holdings, Inc.
—
NYSE ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1860543 ·
Last close
$28.17
Market Cap
$1.21B
52W High
$34.28
52W Low
$25.73
ADV30
411,067
Next earnings
2026-08-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 155,429,000 | 60,166,000 | 9,333,000 | 1,975,000 | 879,736,000 | 41,272,000 | 543,620,000 |
| Dec 2025 | 167,224,000 | 72,623,000 | 21,896,000 | 11,739,000 | 770,031,000 | 122,898,000 | 452,227,000 |
| Sep 2025 | 155,869,000 | 66,625,000 | 20,890,000 | 10,941,000 | 792,055,000 | 150,875,000 | 451,681,000 |
| Jun 2025 | 157,109,000 | 64,249,000 | 18,011,000 | 12,211,000 | 794,437,000 | 137,469,000 | 461,977,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$68,835,000
Investing CF
$-251,293,000
Financing CF
$92,290,000
CapEx
$-8,227,000
Dividends Paid
$-15,871,000
Buybacks
—
EPS Diluted TTM
$0.89
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$32,463,000
Inventory
$130,989,000
Receivables
$111,292,000
ST Investments
—
EBIT TTM
$67,069,000
Pretax Income TTM
$52,549,000
Interest Exp TTM
$14,520,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$635,630,976
EBITDA
$97,490,000
Free Cash Flow
$23,675,624
Enterprise Value
$1,577,938,688
Total Cash
$42,185,000
Total Debt
$389,696,992
Shares Out
42,797,451
Trailing EPS
$0.84
Book Value
$7.85
ROE
11.3%
ROA
6.3%
Div Yield
1.36%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 610,308,000 | 75,047,000 | 44,139,000 | 770,031,000 | 452,227,000 | — | 63,705,000 |
| Dec 2024 | 567,561,000 | 72,768,000 | 36,133,000 | 652,713,000 | 341,198,000 | — | 31,777,000 |
| Dec 2023 | 482,532,000 | 58,711,000 | 38,641,000 | 431,179,000 | 234,017,000 | — | 73,209,000 |
| Dec 2022 | 457,837,000 | 21,071,000 | 5,820,000 | 391,952,000 | 226,062,000 | — | 46,409,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$1.43
Max Pain — expiry 2026-10-16 (volume-derived — Yahoo OI feed degraded)
max pain strike: $20.00 · spot: $28.17 · call volume: 69 · put volume: 20
Expected Move to 2026-10-16:
±$5.60
(19.88%) —
implied range
$22.57 –
$33.77
· ATM straddle on $30.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ENOV | Enovis CORP | $1.20B | $20.85 | — |
| PRCT | PROCEPT BioRobotics Corp | $1.19B | $20.91 | — |
| INSP | Inspire Medical Systems, Inc. | $1.18B | $41.12 | — |
| AVNS | AVANOS MEDICAL, INC. | $1.17B | $24.87 | — |
| IRMD | IRADIMED CORP | $1.16B | $91.09 | — |
News headlines (Yahoo Finance, 1h cache)
3 Market-Beating Stocks with Exciting Potential
2026-06-16 09:00 · Yahoo
1 Russell 2000 Stock to Consider Right Now and 2 Facing Challenges
2026-06-12 14:37 · Yahoo
2 Reasons to Like CDRE and 1 to Stay Skeptical
2026-06-10 11:45 · Yahoo
Cadre Holdings Subsidiary Safariland Selected as Ballistic Provider for FBI Armor Contract
2026-06-02 20:15 · Yahoo
How The Investment Story For Cadre Holdings (CDRE) Is Evolving With An Unchanged Price Target
2026-06-01 16:05 · Yahoo
2 Industrials Stocks with Competitive Advantages and 1 We Turn Down
2026-05-28 16:54 · Yahoo
3 Profitable Stocks to Consider Right Now
2026-05-27 12:33 · Yahoo
1 Stock Under $50 Worth Investigating and 2 Facing Challenges
2026-05-23 14:44 · Yahoo
Our Cadre Holdings Pick Has Disappointed. We’re Sticking With It.
2026-05-23 05:58 · Yahoo
2 of Wall Street’s Favorite Stocks Worth Investigating and 1 Facing Challenges
2026-05-21 06:20 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.